-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TxywcDo57pWhu/9426piB1PaZttKIL7TId/phDGq2u5x6EioQ5VxJi4oOX8ytFHQ V4sZ4qpQKxZC3QxxSCD2ZQ== 0000064670-07-000093.txt : 20071031 0000064670-07-000093.hdr.sgml : 20071030 20071031130526 ACCESSION NUMBER: 0000064670-07-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071029 FILED AS OF DATE: 20071031 DATE AS OF CHANGE: 20071031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAWKINS WILLIAM A CENTRAL INDEX KEY: 0001106508 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 071202008 BUSINESS ADDRESS: STREET 1: MEDTRONIC INC STREET 2: 710 MEDTRONIC PKWY, MS LC 310 CITY: MINNEAPOLIS STATE: MN ZIP: 55432-5604 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: MEDTRONIC INC STREET 2: 710 MEDTRONIC PKWY, MS LC310 CITY: MINNEAPOLIS STATE: MN ZIP: 55432-5604 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2007-10-29 0000064670 MEDTRONIC INC MDT 0001106508 HAWKINS WILLIAM A MEDTRONIC, INC. 710 MEDTRONIC PARKWAY, M.S. LC310 MINNEAPOLIS MN 55432-5604 1 1 0 0 President & Chief Exec Officer Common Stock 2007-10-29 4 A 0 52335 0 A 205930.373 D Common Stock 616.728 I by 401(k) Common Stock 1028.879 I by ESOP Common Stock 400 I By IRA account Stock Options (Right to buy) 47.77 2007-10-29 4 A 0 188403 0 A 2008-10-29 2017-10-29 Common Stock 188403 188403 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. The restrictions on these shares shall lapse 100% on the third anniversay of the grant date if the Company's cumulative earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2010 equals or exceeds a 9% compound annual growth rate, as determined by the Compensation Committee. This balance increased by 131.543 due to exempt transactions including dividend reinvestment and dividend equivalent credits. James N. Spolar, Attorney-in-fact 2007-10-31 -----END PRIVACY-ENHANCED MESSAGE-----